Chesney C M, Pifer D, Colman R W
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5180-4. doi: 10.1073/pnas.78.8.5180.
Factor V, a plasma protein cofactor necessary for optimal conversion of prothrombin to thrombin, is also present in considerable concentration in blood platelets (9.9 units per 10(9) platelets). Subcellular fractionation by two methods has localized factor V in the alpha granules of unstimulated platelets. ADP and epinephrine cause release of 4.6% and 6.4%, respectively, of the total factor V, a process completely inhibited by cyclooxygenase alkylation by aspirin. In contrast, collagen causes release of 25% of platelet factor V, a process only partially suppressed by aspirin. Secretion of factor V depends on the availability of metabolic energy, because antimycin A, an inhibitor of aerobic metabolism, and 2-deoxyglucose, an inhibitor of anaerobic glycolysis, together almost totally inhibited the secretion of factor V induced by collagen. The data establish that factor V is not normally available on unstimulated platelets but can be secreted from alpha granules upon stimulation with physiological agents such as ADP, epinephrine, and collagen. Because factor V is known to serve as a receptor for factor Xa, the exposure of factor V on platelets consequent to release would accelerate the process of blood coagulation.
凝血因子V是凝血酶原向凝血酶最佳转化所必需的一种血浆蛋白辅因子,在血小板中也有相当高的浓度(每10⁹个血小板含9.9单位)。通过两种方法进行亚细胞分级分离已将凝血因子V定位在未受刺激血小板的α颗粒中。ADP和肾上腺素分别导致总凝血因子V释放4.6%和6.4%,这一过程被阿司匹林对环氧合酶的烷基化作用完全抑制。相比之下,胶原导致血小板凝血因子V释放25%,这一过程仅被阿司匹林部分抑制。凝血因子V的分泌取决于代谢能量的可用性,因为需氧代谢抑制剂抗霉素A和无氧糖酵解抑制剂2-脱氧葡萄糖共同几乎完全抑制了胶原诱导的凝血因子V的分泌。这些数据表明,凝血因子V在未受刺激的血小板中通常不可用,但在受到ADP、肾上腺素和胶原等生理因子刺激时可从α颗粒中分泌出来。由于已知凝血因子V可作为因子Xa的受体,释放后血小板上凝血因子V的暴露会加速血液凝固过程。